ATE484587T1 - Ldcam genannte moleküle - Google Patents

Ldcam genannte moleküle

Info

Publication number
ATE484587T1
ATE484587T1 AT99942039T AT99942039T ATE484587T1 AT E484587 T1 ATE484587 T1 AT E484587T1 AT 99942039 T AT99942039 T AT 99942039T AT 99942039 T AT99942039 T AT 99942039T AT E484587 T1 ATE484587 T1 AT E484587T1
Authority
AT
Austria
Prior art keywords
ldcam
molecules called
polypeptides
purified
compositions
Prior art date
Application number
AT99942039T
Other languages
English (en)
Inventor
Peter Baum
William Fanslow
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE484587T1 publication Critical patent/ATE484587T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Vending Machines For Individual Products (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT99942039T 1998-08-07 1999-08-05 Ldcam genannte moleküle ATE484587T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9567298P 1998-08-07 1998-08-07
PCT/US1999/017905 WO2000008158A2 (en) 1998-08-07 1999-08-05 Molecules designated ldcam

Publications (1)

Publication Number Publication Date
ATE484587T1 true ATE484587T1 (de) 2010-10-15

Family

ID=22253083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99942039T ATE484587T1 (de) 1998-08-07 1999-08-05 Ldcam genannte moleküle

Country Status (11)

Country Link
US (5) US7402655B2 (de)
EP (1) EP1102848B1 (de)
JP (1) JP4426724B2 (de)
AT (1) ATE484587T1 (de)
AU (1) AU776825B2 (de)
CA (1) CA2337100C (de)
DE (1) DE69942861D1 (de)
ES (1) ES2353637T3 (de)
IL (3) IL140937A0 (de)
NZ (1) NZ510356A (de)
WO (1) WO2000008158A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ510356A (en) * 1998-08-07 2004-12-24 Immunex Corp Molecules designated LDCAM
AU2588000A (en) * 1998-12-02 2000-06-19 Icos Corporation Novel adhesion molecule and methods of use
EP1514933A1 (de) * 1999-07-08 2005-03-16 Research Association for Biotechnology Sekretorische- oder Membranproteine
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
CA2388032A1 (en) * 1999-10-18 2001-04-26 Texas Biotechnology Corporation Polynucleotides encoding human and murine adhesion proteins (bigr)
US6596493B1 (en) * 2000-08-15 2003-07-22 The Johns Hopkins University School Of Medicine Diagnosis and treatment of tumor-suppressor associated disorders
MY140679A (en) * 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
US20050232896A1 (en) * 2001-10-04 2005-10-20 Herbert Schwarz Cd137 as a proliferation factor for hematopoietic stem cells
JP2006502978A (ja) * 2002-06-17 2006-01-26 ワイス ブチロフィリン4またはb7−l1によるt細胞活性化阻害
EP1648935A2 (de) * 2003-07-25 2006-04-26 Amgen Inc. Antagonisten und agonisten von ldcam und anwendungsverfahren
ES2625259T3 (es) 2006-08-29 2017-07-19 Oxford Biotherapeutics Ltd Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón
US8737317B2 (en) * 2008-05-13 2014-05-27 Qualcomm Incorporated Autonomous carrier selection for femtocells
US8420084B2 (en) 2009-03-05 2013-04-16 Medarex, Inc. Fully human antibodies specific to CADM1
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
WO2014144817A2 (en) 2013-03-15 2014-09-18 Amgen Inc. Inhibitory polypeptides specific to wnt inhibitors
EP3712166A1 (de) 2013-09-05 2020-09-23 Amgen Inc. Fc-haltige moleküle mit vorhersagbaren, konsistenten und reproduzierbaren glycoformprofilen
US10156562B2 (en) 2014-05-16 2018-12-18 Amgen Inc. Assay for detecting Th1 and Th2 cell populations
US11978336B2 (en) 2015-07-07 2024-05-07 Ilumi Solutions, Inc. Wireless control device and methods thereof
WO2017007926A1 (en) 2015-07-07 2017-01-12 Ilumi Solutions, Inc. Wireless communication methods
AU2018235928B2 (en) 2017-03-14 2023-09-21 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
BR112020019559A2 (pt) 2018-03-26 2021-01-12 Amgen Inc. Glicoformas afucosiladas totais de anticorpos produzidos em cultura de células
MX2022003461A (es) 2019-09-26 2022-04-19 Amgen Inc Metodos de produccion de composiciones de anticuerpos.
WO2021247892A1 (en) 2020-06-04 2021-12-09 Amgen Inc. Assessment of cleaning procedures of a biotherapeutic manufacturing process
AU2021360897A1 (en) 2020-10-15 2023-05-25 Amgen Inc. Relative unpaired glycans in antibody production methods
EP4352094A1 (de) 2021-06-07 2024-04-17 Amgen Inc. Verwendung von fucosidase zur steuerung des afucosylierungsniveaus glykosylierter proteine
AU2022361382A1 (en) 2021-10-05 2024-03-28 Amgen Inc. Fc-gamma receptor ii binding and glycan content
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
WO2024220916A1 (en) 2023-04-20 2024-10-24 Amgen Inc. Methods of determining relative unpaired glycan content
WO2025038600A1 (en) 2023-08-14 2025-02-20 Amgen Inc. Methods for reducing yellow color
WO2025101820A1 (en) 2023-11-08 2025-05-15 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642360B2 (en) * 1997-12-03 2003-11-04 Genentech, Inc. Secreted polypeptides that stimulate release of proteoglycans from cartilage
CA2311640A1 (en) * 1997-12-03 1999-06-10 Genentech, Inc. Polypeptides and nucleic acids encoding the same
US20020165143A1 (en) * 1997-12-03 2002-11-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2003525575A (ja) 1998-05-07 2003-09-02 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー 分泌蛋白およびそれらをコードするポリヌクレオチド
IL140938A0 (en) * 1998-08-07 2002-02-10 Immunex Corp Molecules designated b7l-1
NZ510356A (en) * 1998-08-07 2004-12-24 Immunex Corp Molecules designated LDCAM
WO2000029435A1 (en) 1998-10-28 2000-05-25 Human Genome Sciences, Inc. 12 human secreted proteins
EP1135495A2 (de) 1998-12-01 2001-09-26 Genentech, Inc. Ausgeschiedene und transmembran-polypeptide und dafür kodierende nukleinsäure
CA2339404A1 (en) 1999-06-30 2001-01-04 Sigma-Aldrich Co. Synthetic peptide immunogens and antibodies thereto
EP1285084A1 (de) 2000-01-25 2003-02-26 Hyseq, Inc. Neuartige nukleinsäure und polypeptide
AU2001296301A1 (en) 2000-09-26 2002-04-08 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies

Also Published As

Publication number Publication date
DE69942861D1 (de) 2010-11-25
JP4426724B2 (ja) 2010-03-03
EP1102848A2 (de) 2001-05-30
IL193886A0 (en) 2009-05-04
US20090011499A1 (en) 2009-01-08
IL140937A (en) 2010-05-31
JP2002523021A (ja) 2002-07-30
US7659385B2 (en) 2010-02-09
US20100215572A1 (en) 2010-08-26
NZ510356A (en) 2004-12-24
CA2337100A1 (en) 2000-02-17
ES2353637T3 (es) 2011-03-03
EP1102848B1 (de) 2010-10-13
US7402655B2 (en) 2008-07-22
US7741115B2 (en) 2010-06-22
AU776825B2 (en) 2004-09-23
US20040204568A1 (en) 2004-10-14
US20020168712A1 (en) 2002-11-14
IL140937A0 (en) 2002-02-10
IL193886A (en) 2010-12-30
WO2000008158A2 (en) 2000-02-17
US20090155845A1 (en) 2009-06-18
AU5550399A (en) 2000-02-28
WO2000008158A3 (en) 2000-05-11
CA2337100C (en) 2011-09-20

Similar Documents

Publication Publication Date Title
DE69942861D1 (de) Ldcam genannte moleküle
ATE415480T1 (de) B7l-1 moleküle
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
ATE184052T1 (de) Gdf-1 und uog1 proteine
DK1015586T3 (da) TIE-receptortyrosinkinaseligandhomologer
DK1129190T3 (da) Human TSLP DNA og polypeptider
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
PT917571E (pt) Gene relacionado com agouti
DK0804558T3 (da) Tripeptidylaminopeptidase
AU7303301A (en) Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
SE9801455D0 (sv) New receptor
DK1082423T3 (da) Cyclin E2-gener og -proteiner
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
ATE408687T1 (de) Semaphorin polypeptide
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
ZA99445B (en) Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof.
SE9604439D0 (sv) New receptor
DE69827808D1 (de) Protease-ähnliches protein
HK1031229A (en) Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties